Alliancebernstein L.P. Solid Biosciences Inc. Transaction History

Alliancebernstein L.P.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.43 - $1.24 $20,081 - $57,908	-46,700 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$0.74 - $1.79 $8,510 - $20,585	-11,500 Reduced 19.76%	46,700 $56,000
Q2 2021 Jul 30, 2021	BUY	$3.49 - $5.51 $74,686 - $117,914	21,400 Added 58.15%	58,200 $213,000
Q1 2021 May 06, 2021	SELL	$5.37 - $10.72 $28,461 - $56,816	-5,300 Reduced 12.59%	36,800 $204,000
Q4 2020 Feb 08, 2021	SELL	$3.08 - $7.79 $42,504 - $107,502	-13,800 Reduced 24.69%	42,100 $319,000
Q3 2020 Nov 12, 2020	SELL	$2.02 - $3.08 $18,180 - $27,720	-9,000 Reduced 13.87%	55,900 $113,000
Q2 2020 Aug 13, 2020	BUY	$2.1 - $3.42 $20,790 - $33,858	9,900 Added 18.0%	64,900 $190,000
Q1 2020 May 14, 2020	BUY	$2.31 - $4.43 $10,164 - $19,492	4,400 Added 8.7%	55,000 $131,000
Q3 2019 Nov 14, 2019	BUY	$4.33 - $11.64 $32,475 - $87,300	7,500 Added 17.4%	50,600 $523,000
Q2 2019 Aug 14, 2019	BUY	$4.6 - $10.13 $41,400 - $91,170	9,000 Added 26.39%	43,100 $248,000
Q1 2019 May 14, 2019	BUY	$7.19 - $32.37 $86,999 - $391,676	12,100 Added 55.0%	34,100 $314,000
Q3 2018 Nov 08, 2018	BUY	$36.35 - $51.7 $167,210 - $237,820	4,600 Added 26.44%	22,000 $1.04 Million
Q2 2018 Aug 13, 2018	BUY	$7.33 - $43.15 $127,542 - $750,810	17,400 New	17,400 $620,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $24.3M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.